Global Central Nervous System Therapeutic Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Central Nervous System Therapeutic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 OTC
  • 1.2.3 Rx Drugs
• 1.3 Market by Application
  • 1.3.1 Global Central Nervous System Therapeutic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital
  • 1.3.3 Retail Pharmacy
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Central Nervous System Therapeutic Market Perspective (2017-2028)
• 2.2 Central Nervous System Therapeutic Growth Trends by Region
  • 2.2.1 Central Nervous System Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Central Nervous System Therapeutic Historic Market Size by Region (2017-2022)
  • 2.2.3 Central Nervous System Therapeutic Forecasted Market Size by Region (2023-2028)
• 2.3 Central Nervous System Therapeutic Market Dynamics
  • 2.3.1 Central Nervous System Therapeutic Industry Trends
  • 2.3.2 Central Nervous System Therapeutic Market Drivers
  • 2.3.3 Central Nervous System Therapeutic Market Challenges
  • 2.3.4 Central Nervous System Therapeutic Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Central Nervous System Therapeutic Players by Revenue
  • 3.1.1 Global Top Central Nervous System Therapeutic Players by Revenue (2017-2022)
  • 3.1.2 Global Central Nervous System Therapeutic Revenue Market Share by Players (2017-2022)
• 3.2 Global Central Nervous System Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Central Nervous System Therapeutic Revenue
• 3.4 Global Central Nervous System Therapeutic Market Concentration Ratio
  • 3.4.1 Global Central Nervous System Therapeutic Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Therapeutic Revenue in 2021
• 3.5 Central Nervous System Therapeutic Key Players Head office and Area Served
• 3.6 Key Players Central Nervous System Therapeutic Product Solution and Service
• 3.7 Date of Enter into Central Nervous System Therapeutic Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Central Nervous System Therapeutic Breakdown Data by Type

• 4.1 Global Central Nervous System Therapeutic Historic Market Size by Type (2017-2022)
• 4.2 Global Central Nervous System Therapeutic Forecasted Market Size by Type (2023-2028)

5 Central Nervous System Therapeutic Breakdown Data by Application

• 5.1 Global Central Nervous System Therapeutic Historic Market Size by Application (2017-2022)
• 5.2 Global Central Nervous System Therapeutic Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Central Nervous System Therapeutic Market Size (2017-2028)
• 6.2 North America Central Nervous System Therapeutic Market Size by Type
  • 6.2.1 North America Central Nervous System Therapeutic Market Size by Type (2017-2022)
  • 6.2.2 North America Central Nervous System Therapeutic Market Size by Type (2023-2028)
  • 6.2.3 North America Central Nervous System Therapeutic Market Share by Type (2017-2028)
• 6.3 North America Central Nervous System Therapeutic Market Size by Application
  • 6.3.1 North America Central Nervous System Therapeutic Market Size by Application (2017-2022)
  • 6.3.2 North America Central Nervous System Therapeutic Market Size by Application (2023-2028)
  • 6.3.3 North America Central Nervous System Therapeutic Market Share by Application (2017-2028)
• 6.4 North America Central Nervous System Therapeutic Market Size by Country
  • 6.4.1 North America Central Nervous System Therapeutic Market Size by Country (2017-2022)
  • 6.4.2 North America Central Nervous System Therapeutic Market Size by Country (2023-2028)
  • 6.4.3 the United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Central Nervous System Therapeutic Market Size (2017-2028)
• 7.2 Europe Central Nervous System Therapeutic Market Size by Type
  • 7.2.1 Europe Central Nervous System Therapeutic Market Size by Type (2017-2022)
  • 7.2.2 Europe Central Nervous System Therapeutic Market Size by Type (2023-2028)
  • 7.2.3 Europe Central Nervous System Therapeutic Market Share by Type (2017-2028)
• 7.3 Europe Central Nervous System Therapeutic Market Size by Application
  • 7.3.1 Europe Central Nervous System Therapeutic Market Size by Application (2017-2022)
  • 7.3.2 Europe Central Nervous System Therapeutic Market Size by Application (2023-2028)
  • 7.3.3 Europe Central Nervous System Therapeutic Market Share by Application (2017-2028)
• 7.4 Europe Central Nervous System Therapeutic Market Size by Country
  • 7.4.1 Europe Central Nervous System Therapeutic Market Size by Country (2017-2022)
  • 7.4.2 Europe Central Nervous System Therapeutic Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Central Nervous System Therapeutic Market Size (2017-2028)
• 8.2 Asia-Pacific Central Nervous System Therapeutic Market Size by Type
  • 8.2.1 Asia-Pacific Central Nervous System Therapeutic Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Central Nervous System Therapeutic Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Central Nervous System Therapeutic Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Central Nervous System Therapeutic Market Size by Application
  • 8.3.1 Asia-Pacific Central Nervous System Therapeutic Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Central Nervous System Therapeutic Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Central Nervous System Therapeutic Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Central Nervous System Therapeutic Market Size by Region
  • 8.4.1 Asia-Pacific Central Nervous System Therapeutic Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Central Nervous System Therapeutic Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Central Nervous System Therapeutic Market Size (2017-2028)
• 9.2 Latin America Central Nervous System Therapeutic Market Size by Type
  • 9.2.1 Latin America Central Nervous System Therapeutic Market Size by Type (2017-2022)
  • 9.2.2 Latin America Central Nervous System Therapeutic Market Size by Type (2023-2028)
  • 9.2.3 Latin America Central Nervous System Therapeutic Market Share by Type (2017-2028)
• 9.3 Latin America Central Nervous System Therapeutic Market Size by Application
  • 9.3.1 Latin America Central Nervous System Therapeutic Market Size by Application (2017-2022)
  • 9.3.2 Latin America Central Nervous System Therapeutic Market Size by Application (2023-2028)
  • 9.3.3 Latin America Central Nervous System Therapeutic Market Share by Application (2017-2028)
• 9.4 Latin America Central Nervous System Therapeutic Market Size by Country
  • 9.4.1 Latin America Central Nervous System Therapeutic Market Size by Country (2017-2022)
  • 9.4.2 Latin America Central Nervous System Therapeutic Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Central Nervous System Therapeutic Market Size (2017-2028)
• 10.2 Middle East & Africa Central Nervous System Therapeutic Market Size by Type
  • 10.2.1 Middle East & Africa Central Nervous System Therapeutic Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Central Nervous System Therapeutic Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Central Nervous System Therapeutic Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Central Nervous System Therapeutic Market Size by Application
  • 10.3.1 Middle East & Africa Central Nervous System Therapeutic Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Central Nervous System Therapeutic Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Central Nervous System Therapeutic Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Central Nervous System Therapeutic Market Size by Country
  • 10.4.1 Middle East & Africa Central Nervous System Therapeutic Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Central Nervous System Therapeutic Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Biogen
  • 11.1.1 Biogen Company Details
  • 11.1.2 Biogen Business Overview
  • 11.1.3 Biogen Central Nervous System Therapeutic Introduction
  • 11.1.4 Biogen Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.1.5 Biogen Recent Developments
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Details
  • 11.2.2 Pfizer Business Overview
  • 11.2.3 Pfizer Central Nervous System Therapeutic Introduction
  • 11.2.4 Pfizer Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.2.5 Pfizer Recent Developments
• 11.3 Teva
  • 11.3.1 Teva Company Details
  • 11.3.2 Teva Business Overview
  • 11.3.3 Teva Central Nervous System Therapeutic Introduction
  • 11.3.4 Teva Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.3.5 Teva Recent Developments
• 11.4 Novartis
  • 11.4.1 Novartis Company Details
  • 11.4.2 Novartis Business Overview
  • 11.4.3 Novartis Central Nervous System Therapeutic Introduction
  • 11.4.4 Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.4.5 Novartis Recent Developments
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Company Details
  • 11.5.2 Johnson & Johnson Business Overview
  • 11.5.3 Johnson & Johnson Central Nervous System Therapeutic Introduction
  • 11.5.4 Johnson & Johnson Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.5.5 Johnson & Johnson Recent Developments
• 11.6 EliLilly
  • 11.6.1 EliLilly Company Details
  • 11.6.2 EliLilly Business Overview
  • 11.6.3 EliLilly Central Nervous System Therapeutic Introduction
  • 11.6.4 EliLilly Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.6.5 EliLilly Recent Developments
• 11.7 Otsuka
  • 11.7.1 Otsuka Company Details
  • 11.7.2 Otsuka Business Overview
  • 11.7.3 Otsuka Central Nervous System Therapeutic Introduction
  • 11.7.4 Otsuka Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.7.5 Otsuka Recent Developments
• 11.8 Merck
  • 11.8.1 Merck Company Details
  • 11.8.2 Merck Business Overview
  • 11.8.3 Merck Central Nervous System Therapeutic Introduction
  • 11.8.4 Merck Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.8.5 Merck Recent Developments
• 11.9 AstraZeneca
  • 11.9.1 AstraZeneca Company Details
  • 11.9.2 AstraZeneca Business Overview
  • 11.9.3 AstraZeneca Central Nervous System Therapeutic Introduction
  • 11.9.4 AstraZeneca Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.9.5 AstraZeneca Recent Developments
• 11.10 Novartis
  • 11.10.1 Novartis Company Details
  • 11.10.2 Novartis Business Overview
  • 11.10.3 Novartis Central Nervous System Therapeutic Introduction
  • 11.10.4 Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.10.5 Novartis Recent Developments
• 11.11 Takeda
  • 11.11.1 Takeda Company Details
  • 11.11.2 Takeda Business Overview
  • 11.11.3 Takeda Central Nervous System Therapeutic Introduction
  • 11.11.4 Takeda Revenue in Central Nervous System Therapeutic Business (2017-2022)
  • 11.11.5 Takeda Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Central Nervous System Therapeutic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of OTC
• Table 3. Key Players of Rx Drugs
• Table 4. Global Central Nervous System Therapeutic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 5. Global Central Nervous System Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 6. Global Central Nervous System Therapeutic Market Size by Region (2017-2022) & (US$ Million)
• Table 7. Global Central Nervous System Therapeutic Market Share by Region (2017-2022)
• Table 8. Global Central Nervous System Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 9. Global Central Nervous System Therapeutic Market Share by Region (2023-2028)
• Table 10. Central Nervous System Therapeutic Market Trends
• Table 11. Central Nervous System Therapeutic Market Drivers
• Table 12. Central Nervous System Therapeutic Market Challenges
• Table 13. Central Nervous System Therapeutic Market Restraints
• Table 14. Global Central Nervous System Therapeutic Revenue by Players (2017-2022) & (US$ Million)
• Table 15. Global Central Nervous System Therapeutic Revenue Share by Players (2017-2022)
• Table 16. Global Top Central Nervous System Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapeutic as of 2021)
• Table 17. Ranking of Global Top Central Nervous System Therapeutic Companies by Revenue (US$ Million) in 2021
• Table 18. Global 5 Largest Players Market Share by Central Nervous System Therapeutic Revenue (CR5 and HHI) & (2017-2022)
• Table 19. Key Players Headquarters and Area Served
• Table 20. Key Players Central Nervous System Therapeutic Product Solution and Service
• Table 21. Date of Enter into Central Nervous System Therapeutic Market
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Central Nervous System Therapeutic Market Size by Type (2017-2022) & (US$ Million)
• Table 24. Global Central Nervous System Therapeutic Revenue Market Share by Type (2017-2022)
• Table 25. Global Central Nervous System Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 26. Global Central Nervous System Therapeutic Revenue Market Share by Type (2023-2028)
• Table 27. Global Central Nervous System Therapeutic Market Size by Application (2017-2022) & (US$ Million)
• Table 28. Global Central Nervous System Therapeutic Revenue Share by Application (2017-2022)
• Table 29. Global Central Nervous System Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 30. Global Central Nervous System Therapeutic Revenue Share by Application (2023-2028)
• Table 31. North America Central Nervous System Therapeutic Market Size by Type (2017-2022) & (US$ Million)
• Table 32. North America Central Nervous System Therapeutic Market Size by Type (2023-2028) & (US$ Million)
• Table 33. North America Central Nervous System Therapeutic Market Size by Application (2017-2022) & (US$ Million)
• Table 34. North America Central Nervous System Therapeutic Market Size by Application (2023-2028) & (US$ Million)
• Table 35. North America Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
• Table 36. North America Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
• Table 37. Europe Central Nervous System Therapeutic Market Size by Type (2017-2022) & (US$ Million)
• Table 38. Europe Central Nervous System Therapeutic Market Size by Type (2023-2028) & (US$ Million)
• Table 39. Europe Central Nervous System Therapeutic Market Size by Application (2017-2022) & (US$ Million)
• Table 40. Europe Central Nervous System Therapeutic Market Size by Application (2023-2028) & (US$ Million)
• Table 41. Europe Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
• Table 42. Europe Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
• Table 43. Asia Pacific Central Nervous System Therapeutic Market Size by Type (2017-2022) & (US$ Million)
• Table 44. Asia Pacific Central Nervous System Therapeutic Market Size by Type (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Central Nervous System Therapeutic Market Size by Application (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Central Nervous System Therapeutic Market Size by Application (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Central Nervous System Therapeutic Market Size by Region (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Central Nervous System Therapeutic Market Size by Region (2023-2028) & (US$ Million)
• Table 49. Latin America Central Nervous System Therapeutic Market Size by Type (2017-2022) & (US$ Million)
• Table 50. Latin America Central Nervous System Therapeutic Market Size by Type (2023-2028) & (US$ Million)
• Table 51. Latin America Central Nervous System Therapeutic Market Size by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Central Nervous System Therapeutic Market Size by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Central Nervous System Therapeutic Market Size by Type (2017-2022) & (US$ Million)
• Table 56. Middle East and Africa Central Nervous System Therapeutic Market Size by Type (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Central Nervous System Therapeutic Market Size by Application (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Central Nervous System Therapeutic Market Size by Application (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
• Table 61. Biogen Company Details
• Table 62. Biogen Business Overview
• Table 63. Biogen Central Nervous System Therapeutic Product
• Table 64. Biogen Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 65. Biogen Recent Developments
• Table 66. Pfizer Company Details
• Table 67. Pfizer Business Overview
• Table 68. Pfizer Central Nervous System Therapeutic Product
• Table 69. Pfizer Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 70. Pfizer Recent Developments
• Table 71. Teva Company Details
• Table 72. Teva Business Overview
• Table 73. Teva Central Nervous System Therapeutic Product
• Table 74. Teva Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 75. Teva Recent Developments
• Table 76. Novartis Company Details
• Table 77. Novartis Business Overview
• Table 78. Novartis Central Nervous System Therapeutic Product
• Table 79. Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 80. Novartis Recent Developments
• Table 81. Johnson & Johnson Company Details
• Table 82. Johnson & Johnson Business Overview
• Table 83. Johnson & Johnson Central Nervous System Therapeutic Product
• Table 84. Johnson & Johnson Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 85. Johnson & Johnson Recent Developments
• Table 86. EliLilly Company Details
• Table 87. EliLilly Business Overview
• Table 88. EliLilly Central Nervous System Therapeutic Product
• Table 89. EliLilly Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 90. EliLilly Recent Developments
• Table 91. Otsuka Company Details
• Table 92. Otsuka Business Overview
• Table 93. Otsuka Central Nervous System Therapeutic Product
• Table 94. Otsuka Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 95. Otsuka Recent Developments
• Table 96. Merck Company Details
• Table 97. Merck Business Overview
• Table 98. Merck Central Nervous System Therapeutic Product
• Table 99. Merck Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 100. Merck Recent Developments
• Table 101. AstraZeneca Company Details
• Table 102. AstraZeneca Business Overview
• Table 103. AstraZeneca Central Nervous System Therapeutic Product
• Table 104. AstraZeneca Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 105. AstraZeneca Recent Developments
• Table 106. Novartis Company Details
• Table 107. Novartis Business Overview
• Table 108. Novartis Central Nervous System Therapeutic Product
• Table 109. Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 110. Novartis Recent Developments
• Table 111. Takeda Company Details
• Table 112. Takeda Business Overview
• Table 113. Takeda Central Nervous System Therapeutic Product
• Table 114. Takeda Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
• Table 115. Takeda Recent Developments
• Table 116. Research Programs/Design for This Report
• Table 117. Key Data Information from Secondary Sources
• Table 118. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Central Nervous System Therapeutic Market Share by Type: 2021 VS 2028
• Figure 2. OTC Features
• Figure 3. Rx Drugs Features
• Figure 4. Global Central Nervous System Therapeutic Market Share by Application: 2021 VS 2028
• Figure 5. Hospital Case Studies
• Figure 6. Retail Pharmacy Case Studies
• Figure 7. Central Nervous System Therapeutic Report Years Considered
• Figure 8. Global Central Nervous System Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 9. Global Central Nervous System Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 10. Global Central Nervous System Therapeutic Market Share by Region: 2021 VS 2028
• Figure 11. Global Central Nervous System Therapeutic Market Share by Players in 2021
• Figure 12. Global Top Central Nervous System Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapeutic as of 2021)
• Figure 13. The Top 10 and 5 Players Market Share by Central Nervous System Therapeutic Revenue in 2021
• Figure 14. North America Central Nervous System Therapeutic Market Size YoY (2017-2028) & (US$ Million)
• Figure 15. North America Central Nervous System Therapeutic Market Size Market Share by Type (2017-2028)
• Figure 16. North America Central Nervous System Therapeutic Market Size Market Share by Application (2017-2028)
• Figure 17. North America Central Nervous System Therapeutic Market Size Share by Country (2017-2028)
• Figure 18. United States Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 19. Canada Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 20. Europe Central Nervous System Therapeutic Market Size YoY (2017-2028) & (US$ Million)
• Figure 21. Europe Central Nervous System Therapeutic Market Size Market Share by Type (2017-2028)
• Figure 22. Europe Central Nervous System Therapeutic Market Size Market Share by Application (2017-2028)
• Figure 23. Europe Central Nervous System Therapeutic Market Size Share by Country (2017-2028)
• Figure 24. Germany Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 25. France Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 26. U.K. Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. Italy Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. Russia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Nordic Countries Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Asia-Pacific Central Nervous System Therapeutic Market Size YoY (2017-2028) & (US$ Million)
• Figure 31. Asia Pacific Central Nervous System Therapeutic Market Size Market Share by Type (2017-2028)
• Figure 32. Asia Pacific Central Nervous System Therapeutic Market Size Market Share by Application (2017-2028)
• Figure 33. Asia Pacific Central Nervous System Therapeutic Market Size Share by Region (2017-2028)
• Figure 34. China Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 35. Japan Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. South Korea Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Southeast Asia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. India Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Australia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 40. Latin America Central Nervous System Therapeutic Market Size YoY (2017-2028) & (US$ Million)
• Figure 41. Latin America Central Nervous System Therapeutic Market Size Market Share by Type (2017-2028)
• Figure 42. Latin America Central Nervous System Therapeutic Market Size Market Share by Application (2017-2028)
• Figure 43. Latin America Central Nervous System Therapeutic Market Size Share by Country (2017-2028)
• Figure 44. Mexico Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 45. Brazil Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 46. Middle East & Africa Central Nervous System Therapeutic Market Size YoY (2017-2028) & (US$ Million)
• Figure 47. Middle East and Africa Central Nervous System Therapeutic Market Size Market Share by Type (2017-2028)
• Figure 48. Middle East and Africa Central Nervous System Therapeutic Market Size Market Share by Application (2017-2028)
• Figure 49. Middle East and Africa Central Nervous System Therapeutic Market Size Share by Country (2017-2028)
• Figure 50. Turkey Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 51. Saudi Arabia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 52. UAE Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Biogen Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 54. Pfizer Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 55. Teva Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 56. Novartis Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 57. Johnson & Johnson Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 58. EliLilly Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 59. Otsuka Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 60. Merck Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 61. AstraZeneca Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 62. Novartis Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 63. Takeda Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
• Figure 64. Bottom-up and Top-down Approaches for This Report
• Figure 65. Data Triangulation
• Figure 66. Key Executives Interviewed